Trends in the cost and utilization of psychotropic medicines for major psychiatric disorders in Bulgaria from 2013 to 2017 K. Tachkov; D. Ignatova; K. Mitov; M. Kamusheva; G. Petrova;

Clinical practice and metabolic consequences of olanzapine use in schizophrenia: results from a national survey in Spain L.I. Muñoz-Manchado; M. Bernardo; J.M. Villagrán-Moreno; E. Fernández-Egea;

Spanish validation of ¿The Awareness of Social Inference Test¿ (TASIT) Lorena García-Fernández; Nuria Cabot-Ivorra; Verónica Romero-Ferreiro; Miguel A. Álvarez-Mon; Estela Jiménez López; Guillermo Lahera; Skye McDonald; Roberto Rodriguez-Jimenez;